The applicant's long-term objective is to understand the pathophysiology of autosomal dominant polycystic kidney disease (ADPKD) as a basis for rational therapy, including gene therapy, of the disease. Recent studies have shed considerable light on the genetic basis of ADPKD. Mutations in PKD1 account for approximately 90 percent of cases. PKD1 encodes a cell-membrane protein, 'polycystin-1', that is most abundantly expressed in various tissues, including the kidney, during embryonic development. One of the most powerful approaches for the study of disease pathogenesis is targeted gene mutation. Standard transgenic technology results in insertion of the transgene at quasi-random sites in the genome so that the transgene and endogenous genes are simultaneously expressed. Gene targeting, by contrast, allows a mutant sequence to be substituted for the allelic endogenous sequence so that the mutation can be studied in the context of the natural chromosomal (regulatory) environment. Two different targeted mutants of Pkd1, the mouse homologue of PKD1, have recently been generated in the P.I.'s laboratory. Homozygotes develop severe polycystic kidney and pancreatic disease and die in the perinatal period. Heterozygotes develop scattered focal renal cysts throughout the kidneys and liver in a manner reminiscent of human ADPKD. The major goal of this proposal is to use these animals to identify the pathways that lead from polycystin-1 mutation to cyst formation. These animals will also be used to test existing hypotheses of cyst formation, including the role of apoptosis and the stimulation of EGF receptors abnormally localized on the apical surfaces of cyst lumens. Tissue- and stage-specific Pkd1-mutants will also be generated using the Cre-loxP system. Targeted mutant mice provide authentic models of human PKD1-disease that can be used to develop and evaluate new therapies for ADPKD. Such studies are much harder to perform in ADPKD patients because of the gradual progression of the disease in man and significant ethical and safety concerns.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
2R01DK051050-05
Application #
6043441
Study Section
General Medicine B Study Section (GMB)
Program Officer
Hirschman, Gladys H
Project Start
1995-09-30
Project End
2004-11-30
Budget Start
2000-03-01
Budget End
2000-11-30
Support Year
5
Fiscal Year
2000
Total Cost
$355,310
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115
Cunha, Gerald R (2016) New and old techniques in cell and developmental biology. Differentiation 91:1-3
Wu, Yong; Xu, Jen X; El-Jouni, Wassim et al. (2016) G?12 is required for renal cystogenesis induced by Pkd1 inactivation. J Cell Sci 129:3675-3684
Yao, Gang; Luo, Chong; Harvey, Michael et al. (2016) Disruption of polycystin-L causes hippocampal and thalamocortical hyperexcitability. Hum Mol Genet 25:448-58
Freedman, Benjamin S; Brooks, Craig R; Lam, Albert Q et al. (2015) Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids. Nat Commun 6:8715
Yao, Gang; Su, Xuefeng; Nguyen, Vy et al. (2014) Polycystin-1 regulates actin cytoskeleton organization and directional cell migration through a novel PC1-Pacsin 2-N-Wasp complex. Hum Mol Genet 23:2769-79
Jin, Xingjian; Muntean, Brian S; Aal-Aaboda, Munaf S et al. (2014) L-type calcium channel modulates cystic kidney phenotype. Biochim Biophys Acta 1842:1518-26
Freedman, Benjamin S; Lam, Albert Q; Sundsbak, Jamie L et al. (2013) Reduced ciliary polycystin-2 in induced pluripotent stem cells from polycystic kidney disease patients with PKD1 mutations. J Am Soc Nephrol 24:1571-86
Yao, Gang; Luyten, Annouck; Takakura, Ayumi et al. (2013) The cytoplasmic protein Pacsin 2 in kidney development and injury repair. Kidney Int 83:426-37
Nauli, Surya M; Jin, Xingjian; AbouAlaiwi, Wissam A et al. (2013) Non-motile primary cilia as fluid shear stress mechanosensors. Methods Enzymol 525:1-20
Qin, Shan; Taglienti, Mary; Cai, Lei et al. (2012) c-Met and NF-ýýB-dependent overexpression of Wnt7a and -7b and Pax2 promotes cystogenesis in polycystic kidney disease. J Am Soc Nephrol 23:1309-18

Showing the most recent 10 out of 28 publications